Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Page 1
Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments.
Kjøller-Hansen L, Bligaard N, Kelbæk H, Christiansen EH, Thuesen L, Hansen PR, Engstrøm T, Junker A, Abildgaard U, Lassen JF, Jensen JS, Jeppesen JL, Galløe AM. Kjøller-Hansen L, et al. Among authors: galloe am. EuroIntervention. 2018 Sep 20;14(7):764-771. doi: 10.4244/EIJ-D-18-00396. EuroIntervention. 2018. PMID: 29969425 Free article.
AIMS: The aim of the study was to determine whether patients treated with drug-eluting stents in the proximal left anterior descending artery (LAD) carried a different long-term prognosis from patients treated in other coronary artery segments. ...CONCLUSIONS: Patients tre …
AIMS: The aim of the study was to determine whether patients treated with drug-eluting stents in the proximal left anterior descending arter …
10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.
Galløe AM, Kelbæk H, Thuesen L, Hansen HS, Ravkilde J, Hansen PR, Christiansen EH, Abildgaard U, Stephansen G, Lassen JF, Engstrøm T, Jensen JS, Jeppesen JL, Bligaard N; SORT OUT II Investigators. Galløe AM, et al. J Am Coll Cardiol. 2017 Feb 14;69(6):616-624. doi: 10.1016/j.jacc.2016.11.055. J Am Coll Cardiol. 2017. PMID: 28183505 Free article. Clinical Trial.
Definite, probable, and possible stent thrombosis appeared in 279 patients (13.3%), with no difference between stent types and with a steady annual rate of 1.3% after the first year. CONCLUSIONS: Among the surviving patients, the long-term annual MACE rate and the stent th …
Definite, probable, and possible stent thrombosis appeared in 279 patients (13.3%), with no difference between stent types and with a steady …
Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents.
Bligaard N, Thuesen L, Saunamäki K, Thayssen P, Aarøe J, Hansen PR, Lassen JF, Stephansen G, Jeppesen JL, Galløe AM; SORT OUT II investigators. Bligaard N, et al. Among authors: galloe am. Scand Cardiovasc J. 2014 Jun;48(3):148-55. doi: 10.3109/14017431.2014.883461. Epub 2014 Feb 26. Scand Cardiovasc J. 2014. PMID: 24548278 Clinical Trial.
OBJECTIVE: Millions of patients were treated with the sirolimus-eluting Cypher and the paclitaxel-eluting Taxus coronary stents with potential late-occurring increase in event rates. Therefore, the long-term outcome follow-up is of major clinical interest. DESIGN: In total …
OBJECTIVE: Millions of patients were treated with the sirolimus-eluting Cypher and the paclitaxel-eluting Taxus coronary stents with potenti …
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
Kufner S, de Waha A, Tomai F, Park SW, Lee SW, Lim DS, Kim MH, Galloe AM, Maeng M, Briguori C, Dibra A, Schömig A, Kastrati A. Kufner S, et al. Among authors: galloe am. Am Heart J. 2011 Oct;162(4):740-7. doi: 10.1016/j.ahj.2011.07.003. Am Heart J. 2011. PMID: 21982668
We addressed this issue by making a synthesis of the available evidence on the relative long-term efficacy and safety of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in these patients. ...Both these DES types are, however, comparable with respect to the …
We addressed this issue by making a synthesis of the available evidence on the relative long-term efficacy and safety of sirolimus-el …
Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis.
Graudal NA, Galløe AM, Garred P. Graudal NA, et al. Among authors: galloe am. JAMA. 1998 May 6;279(17):1383-91. doi: 10.1001/jama.279.17.1383. JAMA. 1998. PMID: 9582047
Reduced sodium intake may be used as a supplementary treatment in hypertension. Further long-term studies of the effects of high reduction of sodium intake on blood pressure and metabolic variables may clarify the disagreements as to the role of reduced sodium intake, but …
Reduced sodium intake may be used as a supplementary treatment in hypertension. Further long-term studies of the effects of high redu …
[No grounds for vasodilatory treatment in pulmonary hypertension].
Petersen JR, Galløe AM, Graudal NA. Petersen JR, et al. Among authors: galloe am. Ugeskr Laeger. 1994 Apr 11;156(15):2219-21, 2224-6. Ugeskr Laeger. 1994. PMID: 8016946 Review. Danish.
It is concluded, that until now no publication has been able to convincingly demonstrate any long-term clinically beneficial effects of vasodilators in patients with secondary pulmonary hypertension....
It is concluded, that until now no publication has been able to convincingly demonstrate any long-term clinically beneficial effects …
Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction.
Galløe AM, Rasmussen HS, Jørgensen LN, Aurup P, Balsløv S, Cintin C, Graudal N, McNair P. Galløe AM, et al. BMJ. 1993 Sep 4;307(6904):585-7. doi: 10.1136/bmj.307.6904.585. BMJ. 1993. PMID: 8401013 Free PMC article. Clinical Trial.
OBJECTIVE: To investigate the effect of long term oral magnesium treatment on incidence of cardiac events among survivors of an acute myocardial infarction. ...When the timing of events was incorporated by means of a Kaplan-Meier plot the treatment group showed a significa …
OBJECTIVE: To investigate the effect of long term oral magnesium treatment on incidence of cardiac events among survivors of an acute …
[Severe obstructive lung disease. The effect of the calcium antagonist isradipine on working capacity, pulmonary function, morbidity and survival].
Petersen JR, Galløe AM, Graudal NA, Galløe M. Petersen JR, et al. Among authors: galloe am. Ugeskr Laeger. 1993 Aug 23;155(34):2612-5. Ugeskr Laeger. 1993. PMID: 8212369 Clinical Trial. Danish.
We therefore designed this first randomized, double-blind, placebo-controlled, long-term study to investigate the clinical effects of a calcium antagonist (isradipine) on patients with COPD. ...
We therefore designed this first randomized, double-blind, placebo-controlled, long-term study to investigate the clinical effects of …
The effect of the calcium antagonist, isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double-blind, placebo-controlled study.
Galløe AM, Graudal N, Petersen JR, Leth P, Galløe M. Galløe AM, et al. J Intern Med. 1991 May;229(5):447-52. doi: 10.1111/j.1365-2796.1991.tb00373.x. J Intern Med. 1991. PMID: 1828266 Clinical Trial.
The clinical implications of these effects are uncertain. The randomized, double-blind, placebo-controlled, long-term study described here is the first to investigate the clinical effects of a calcium antagonist on patients with COPD. ...
The clinical implications of these effects are uncertain. The randomized, double-blind, placebo-controlled, long-term study described …